Key statistics
On Friday, Sana Biotechnology Inc (SANA:NSQ) closed at 4.23, 54.10% above the 52 week low of 2.75 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.36 |
---|---|
High | 4.40 |
Low | 4.22 |
Bid | 4.17 |
Offer | 4.30 |
Previous close | 4.25 |
Average volume | 1.67m |
---|---|
Shares outstanding | 222.47m |
Free float | 203.34m |
P/E (TTM) | -- |
Market cap | 941.03m USD |
EPS (TTM) | -1.15 USD |
Data delayed at least 15 minutes, as of Oct 04 2024 21:00 BST.
More ▼
- Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference
- Sana Biotechnology to Present at September 2024 Investor Conferences
- Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer
- Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates
- Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glial-based Neurodegenerative Conditions
- Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
- Sana Biotechnology to Present at May and June 2024 Investor Conferences
- Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
- Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
- Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
More ▼